Low-Dose (15 mg/day) Pioglitazone Treatment Improves Glycemic Control, and Whole-Body and Adipocyte Insulin Resistance With Minimal Weight Gain in Type 2 Diabetic Subjects
DIABETES(2012)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETES(2012)